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Abstract 
Low-energy conformation search on biological macromolecules remains a 
challenge in biochemical experiments and theoretical studies. Finding efficient 
approaches to minimize the energy of peptide structures is critically needed for 
researchers either studying peptide-protein interactions or designing peptide drugs. In this 
study, we aim to develop a heuristic-based algorithm to efficiently minimize a promising 
PD-L1 inhibiting polypeptide, TPP-1, and build its low-energy conformer pool to 
advance its subsequent structure optimization and molecular docking studies. Through 
our study, we find that, using backbone dihedral angles as the decision variables, both 
PSO and GA can outperform other existing heuristic approaches in optimizing the 
structure of Met-enkephalin, a benchmarking pentapeptide for evaluating the efficiency 
of conformation optimizers. Using the established algorithm pipeline, hybridizing PSO 
and GA minimized TPP-1 structure efficiently and a low-energy pool was built with an 
acceptable computational cost (a couple days using a single laptop). Remarkably, the 
efficiency of hybrid PSO-GA is hundreds-fold higher than the conventional Molecular 
Dynamic simulations running under the force filed. Meanwhile, the stereo-chemical 
quality of the minimized structures was validated using Ramachandran plot. In summary, 
hybrid PSO-GA minimizes TPP-1 structure efficiently and yields a low-energy 
conformer pool within a reasonably short time period. Overall, our approach can be 
extended to biochemical research to speed up the peptide conformation determinations 
and hence can facilitate peptide-involved drug development.      
1 
Chapter 1 : Introduction 
 
1.1 The Rise of Immunotherapy  
Cancer is one of the leading causes of human death on earth. According to the 
statistics from National Cancer institute (NCI), 8.2 million people died of cancer-related 
disease in 2012 with another 1.4 million new cases developed that year worldwide. To 
make it even worse, the number of newly developed cancer cases each year keeps 
increasing. For example, an estimated 1.7 million new cancer patients will be diagnosed 
in the United States in 2018 (https://www.cancer.gov/about-cancer).   
Formed by irregularly shaped cells, tumor typically proliferates in an abnormally 
high growth rate, and it invades neighboring organs and causes damages until functional 
failure/loss of the hosting organ. Due to cell-to-cell heterogeneity and rapid gene 
mutations among tumor cells, malignant tumor is hard to predict at its early stages and 
pharmaceutically difficult to treat. In fact, the current prevailing cancer therapies, i.e. 
chemotherapy and radiotherapy, are still plagued by their accompanying severe adverse 
side effects and low efficacies [1-4].   
Immunotherapy has become a promising alternative treatment for cancer patients 
in recent years after a striking success of several clinical trials targeting human immune 
checkpoints [5-9], mainly referring to the two proteins on T cell surface, i.e. CTLA-4 and 
PD-1 (Fig. 1-1). These two proteins were discovered by two cancer immunologists James 
P. Allison and Tasuku Honjo, respectively. Both of the two scientists were awarded the 
2018 Nobel Prize in Physiology or Medicine for their contributions to unveil the 
complexity of molecular mechanisms regulating the immune responses based upon the 
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two aforementioned immune checkpoints [10], and their important findings laid a solid 
foundation for the blooming of immunotherapy. In plain words, cancer immunotherapy 
targets and destroys cancer cells through enhancing human body’s immune activities by 
releasing some of the ‘brakes’ on the host immune system.   
 
 
Figure 1-1. The immune checkpoints of T-cells.  
Both PD-1 and CTLA-4 are the T-cell receptor responsible for the immune checkpoint. Inhibitor 
drugs exert their functions through blocking the interactions between PD-1 (or CTLA4) and its 
ligand.  
[Nature] REF. 10 © (2018). 
In the past several years, multiple novel cancer immunotherapy drugs have been 
developed as the immune checkpoint antagonists and these approaches have focused on 
anti-PD-1 and anti-PD-L1 checkpoint inhibitors, anti-CTLA-4 monoclonal antibodies 
and immune-modulatory drugs.  Since 2015, the Food and Drug Administration (FDA) 
has approved eight antibody-related immunotherapy drugs targeting either one or 
multiple proteins [11]. In addition, multiple antibody immunotherapy candidates are 
being actively investigated in clinical trials, and some of them have already shown 
potentials to advance to real patient treatments [9, 12]. Chinese FDA also approved its 
first antibody drug used for immunotherapy in the summer of 2018. The pharmaceutical 
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value of immunotherapy has kept increasing and the immunotherapy drugs market is 
projected to reach $201.52 billion by 2021.  This increases from $108.41 billion in 2016, 
with an annual growing rate at 13.5% during the forecasting period [13].  
1.2 Low-energy Conformation Search of TPP-1 
Organic molecules are still the dominating force on the pharmaceutical drug 
market. Approximately 70% of the top 200 pharmaceutical products (ranked by retail 
sales in 2016 by the Njardarson Group at The University of Arizona) are developed from 
small organic molecules. However, adverse side effect caused by the toxicity of organic 
compounds is a major challenge and concern for late stage clinical studies.  
As an alternative strategy, peptide-based pharmaceutical drug development has 
gained increasing attention in recent years considering its natural biodegradability and 
lower toxicity. Whilst less toxic, studying and optimizing short peptide structures are 
more effort-intensive during pre-clinical investigations than designing/synthesizing 
organic compounds because the three dimensional conformations of short peptides tend 
to be more flexible while, in contrast, small organic compounds are usually rigid. The 
structural flexibility of short peptides is mainly attributed to a large number of feasible 
combinations of the dihedral angles within the peptide backbone. Therefore, this causes 
the peptide conformational searching space to be a vast number, rendering the 
computation very expensive. Since peptide low-energy conformers are needed in peptide 
conformation-related studies, such as peptide docking, binding free energy calculations 
and peptide structure optimization. Therefore, low-energy conformational search is 
unavoidable, and naturally, efficient approaches to expedite the peptide low-energy 
conformer searching is critically needed. 
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1.2.1 Discovery of Polypeptide TPP-1 
TPP-1, with an amino acid sequence of SGQYASYHCWCWRNPGRSGGSK, 
has been actively studied in the field of cancer immunotherapy. It was shown to be 
effective in inhibiting cancer cell proliferation and could potentially improve current 
tumor therapy [14]. TPP-1, which works as a PD-L1 blockade agent, was discovered from 
biological high-throughput screening assay for its blocking of the signaling pathway to 
one major immune checkpoint PD-1 on the T-cells. PD-L1 is expressed regularly on the 
normal human cell surfaces and serves as a key cellular signal for T-cells to distinguish 
self-cells from non-self-cells. However, during the course of evolution, mutated tumor 
cells hijack this mechanism by expressing PD-L1 on its own cell surface and take 
advantage of this protein as an escaping tool of human immune surveillance. And 
discovery of TPP-1 has opened new ways to the improvement of immunotherapy tools. 
1.2.2 Polypeptide TPP-1, as an Alternative for Tumor Immunotherapy   
From the perspective of manufacturing pharmaceutical products, the cost of 
producing peptides is much lower than producing antibodies. Moreover, since antibody 
molecules are usually larger in size than peptides, their absorption efficiency is much 
lower in patients’ body when compared with small organic molecules or short peptides. 
However, small organic molecules also suffer from high probability toxicity issues [15-
18], especially in the late stage clinical studies. Considering all these above factors, 
developing short peptides as anti-cancer therapies is more promising. In fact, while 
peptides as a cancer treatment has attracted the therapeutic focus for many years [19, 20] 
only recently it gained a lot of momentum  in the field of immunotherapy.  
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TPP-1, which has been shown to be effective in inhibiting cancer cell 
proliferation, is now regarded as, if not alone, at least a supplemental, promising 
checkpoint immunotherapy strategy through a proposed working mechanism as shown in 
Figure 1-2. Despite encouraging pre-clinical results of TPP-1 [14], structural optimization 
steps will be needed to advance TPP-1 to clinical studies for more comprehensive 
investigations. In fact, conventional computational methodologies to characterize peptide 
structures or to find low-energy conformations are still limited to molecular dynamic 
(MD) simulations using empirical force fields. While the result of MD simulations is 
usually reliable, the execution of this approach is computationally expensive. Thus, in 
order to meet the increasing demand of peptide sequence optimization and low-energy 
structure prediction, it is important to accelerate existing global optimizers through 
designing novel algorithms.  
Finding the low-energy conformers of TPP-1 is beneficial to molecular docking 
studies to characterize the binding poses and binding free energy calculations to evaluate 
the binding strength. For instance, in the optimization of TPP-1 sequence to either 
strengthen or weaken the binding strength to its target, low-energy conformers can be 
utilized to guide the TPP-1 amino acid mutations. In this project, we aim to find the low-
energy conformers of TPP-1 to provide a basis for the subsequent TPP-1: PD-L1 
interaction studies both computationally and experimentally. 
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Figure 1-2. AptPD-L1, a DNA aptamer, blocks PD-1/PD-L1 interaction and attenuates T 
cell suppression.  
The figure is adapted from a paper published in 2016 [21], and the inhibition of tumor cell 
proliferation by TPP-1 is proposed to perform in a similar manner to AptPD-L1. 
[Nucleic Acids] REF. 21 © (2016). 
1.3 Heuristic Approaches  
Heuristic, meaning “to find” or “to discover”, is a strategy that was derived from 
the previous experience accumulated from tackling similar problems. The study of 
heuristic in human decision-making can be dated back to 1970-1980s by psychologists 
Amos Tversky and Daniel Kahneman [22], however, the formal concept of heuristic 
approaches originated with Nobel laureate Herbert A. Simon.  
Heuristic techniques are not guaranteed to find optimal solutions, but practically 
speaking, they do offer an approach to efficiently discover high-quality solutions which 
satisfy goals.  Additionally, metaheuristics for optimization are general frameworks 
which provide rules for guiding heuristic search in optimization problems.  Metaheuristic 
algorithms include well known techniques such as evolutionary algorithms and simulated 
annealing.  Such techniques have been applied to many famous and typical NP-hard 
problems, such as scheduling problems [23-25], knapsack problems [26, 27] and 
travelling salesman problems [28, 29], etc.  
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Heuristic or metaheuristic approaches are usually chosen when finding an exact 
solution to the problem of interest is impractical as it cannot be obtained within an 
acceptable amount of time or with the available computing resources. There are four 
typical principles for applying heuristic methods. These principles can be ordered 
sequentially as: understanding the problem, making a plan, carrying out the plan, and 
evaluating/adapting. These principles were first proposed in a monograph titled “How to 
solve it” by a Hungarian mathematician György (George) Pólya in 1945.  Nowadays, 
these principles have been widely applied to address difficult problems in computer 
science and many other scientific fields. 
1.3.1 Heuristic Approaches in Addressing Scientific Problems 
In theoretical chemistry, intensive calculations are needed to carry out simulations 
of biological molecule conformation changes in a dynamic process. Many heuristic 
methods are implemented in the field of computational chemistry. For example, before 
Molecular Dynamic (MD) simulations, typically steepest descent algorithm was applied 
to quickly orient the molecule to a local lower-energy conformation [30]; in 
computational protein design, multiple stochastic search algorithms were applied and 
compared [31]; in molecular docking software, simulated annealing approach was used 
to bring organic molecules to their low-energy conformations during the docking 
processes [32, 33].  
The application of heuristic approaches can also be found in the field of 
bioinformatics. One example, sequence alignment problem can be very challenging when 
the size and number of sequences increases, researchers have taken the advantages of 
simulated annealing, ant colony optimization and particle swarm optimization approaches 
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to help finding the optimal or near-optimal solutions for efficient DNA sequence 
alignment [34]. 
 
1.3.2 Particle Swarm Optimization and Genetic Algorithm 
 Here, two metaheuristic approaches, Particle Swarm Optimization and Genetic 
Algorithm, are discussed. 
Particle Swarm Optimization (PSO) is first introduced by James Kennedy and 
Russell C. Eberhart in 1995 and since then tens of thousands of papers have been 
published about particle swarms. PSO was inspired by the social behavior of birds and 
shoals of fish and it is a population-based optimization technique. The main advantage of 
PSO is that, with only a few tunable parameters, it is simple to implement. Another 
attractive feature of PSO is that, since it does not require the gradient of the problem being 
optimized, it is applicable to many not-differentiable problems. This makes it distinctive 
from classic optimization methods, such as gradient descent algorithm. Moreover, in 
many cases, PSO tends to converge to the ‘best’ solution quickly and hence it has the 
potential to solve many difficult problems with a high efficiency.  
Genetic algorithm (GA), on the other hand, is inspired by the process of natural 
selection and thus Darwin’s theory of evolution. It is first introduced by John Holland in 
1960. In 1989, his student Goldberg further extended GA into a protocol that is in 
common use today. GA is a powerful meta-heuristic tool being frequently and widely 
used to find near-optimum solutions for many combinational problems in the field of 
business, scientific and engineering. The working principle of GA is rather 
straightforward: during each successive generation, individual solutions with desired 
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fitness, as measured by the evaluation function, are retained and advanced to generate 
offspring, and this step is repeated iteratively till optimized solutions are produced.  
With GA being easily implementable, it is also suitable to hybridize with other 
optimization methods. Other advantages of GA are that it is normally guaranteed to 
improve the current solution and that it also works for problems with a ‘noisy’ 
environment. However, GA has its limitations as well. One major disadvantage is the 
curse of dimensionality. In other words, GA does not scale well with problem complexity. 
The problem search space increases exponentially with the dimension of the problem. In 
addition, for some dynamic problems, GA cannot always produce consistent solutions 
because early convergence issues can become prominent. 
1.3.3 Pros and Cons of Heuristic Approaches  
Overall, applying heuristic approaches for problem-solving can be very beneficial 
and efficient. It tends to provide a quick and relatively inexpensive feedback to us. 
Especially for the early-phase of a designing process, the intuitive feedback from heuristic 
technique would be helpful to problem-designers. However, one major shortcoming of 
using heuristic approaches is that the different heuristic methodologies may perform very 
differently, and no single approach can be used to solve all kinds of problem instances. 
Trained experts are usually required to implement heuristic approaches efficiently and 
effectively, especially in addressing practical scientific questions. 
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Chapter 2 : Both PSO and GA are Efficient in Minimizing Met-
enkephalin  
 
2.1 Introduction 
Peptides are short biopolymers, whose components are the 20 unique amino acids 
in nature. The number of amino acid units within a peptide usually ranges from a few to 
a few tens. When the amino acid number grows even larger, it usually adopts a more rigid 
structure and becomes a protein. In biological systems, peptides perform important 
physiological roles. For example, peptides form one major class of hormones and are 
essential for human homeostasis regulations; some peptides can function as transporters 
mediating the trans-membrane processes of nutrients or small molecules; other peptides 
can function as enzymes to catalyze metabolism reactions. Overall, an appropriate 
concentration and activity levels of peptides are necessary to achieve body homeostasis 
and maintain health. 
Studying peptides is important for not only understanding the fundamental 
molecular mechanism of the endogenous biological system, but also presenting 
tremendous values for pharmaceutical drug development. Especially in recent years, 
developing peptides as cancer therapy drugs have gained increasing attention, because of 
their lower production cost (than antibodies) and less toxicity (than small organic 
compounds).  These two factors will be critically evaluated when a potential drug 
candidate advances into clinical trials. In pre-clinical research, however, emphasis is 
usually placed onto optimizing the binding affinity of the peptide of interest to its 
targeting proteins.  
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Based on the “thermodynamic hypothesis” by Anfinsen in 1973, the native state 
of protein is the structure that minimizes the free energy [35]. In other words, such a 
native state corresponds to the structure conformation with the global minimum energy. 
The immediate question to address is then how to quickly find such a structure with a 
global minimum energy. Performing the conformational search to find this global 
minimum energy is an obvious approach and it is called as a conformational optimization 
problem. Optimizing peptide structures has been a challenging task for many decades 
because of its large conformational searching space caused by a vast number of dihedral 
angle combinations for the peptide backbone. And notably, when the amino acid 
sequence becomes longer, the conformational search space grows exponentially.  
Over the past years, many research have been carried out to apply heuristic 
approaches to facilitate the peptide structure minimization, such as Tabu Search (TS) 
[36], Simulated Annealing (SA) [37], Monte Carlo Minimization (MCM) [38] and 
Conformational Space Annealing (CSA) [39]. However, these optimizers can only 
minimize short (typically less than 10 amino acids) peptide structures because the 
computational cost of searching becomes too high to handle larger peptides. Meanwhile, 
restraints were applied to the dihedral angle combinations. Thus, it is important to fill the 
gap of technologies to perform long peptide conformation searches efficiently and 
effectively.   
In this chapter, the adaptation of Genetic Algorithm, Memetic Algorithm, and 
Particle Swarm Optimization techniques to minimize a common testing peptide, Met-
enkephalin, will be performed. Met-enkephalin, with a primary amino acid sequence 
YGGFM, is an endogenous pentapeptide that has an opioid effect. Met-enkephalin is 
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highly unstable and has a low bioavailability and short half-life (minutes). These 
properties cause difficulties to study this peptide using traditional biochemical 
techniques. That explains why it has attracted many chemists’ attention to study its 
structure computationally. As a benchmarking peptide, it has been widely used to perform 
the evaluation of peptide conformation optimizers.  For a direct comparison with other 
existing approaches, we will also use Met-enkephalin to test our algorithm.  
2.2 Methodology 
2.2.1 Energy Evaluation Function  
Many different force fields for defining the potential energy of protein structures 
have been designed, and the most used ones are ECEPP, OPLS, GROMOS, CHARMM 
and AMBER. In this study, we choose the AMBER force field that is a preferable choice 
among computational chemists when performing the molecular mechanic studies [30].  
Below is the functional form of the AMBER force field; this equation defines the 
potential energy of a macromolecule system (peptide in our case). 
 
The first two terms represent the bond and angle energies, respectively. The last 
term is composed of two parts: van der Waals (non-bonded energy between all atom pairs) 
and electrostatics. The third term, which depends on the torsion angles, will be the only 
energy to be minimized in this study. The principle/fact behind this is that, under 
biological conditions, the dihedral angle changes will primarily determine the overall 
peptide structures; whilst, the bond length and angle terms are relatively constant. Thus, 
to reduce the size of the problem, bond lengths and bond angles will be fixed at their 
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equilibrium values; and the changes to van der Waals and electrostatics during the 
conformation searches were also handled by using the default values in Amber. 
2.2.2 Decision Variables 
In Section 2.2.1, we mentioned that the dihedral angles are the only parameters 
we are trying to optimize. Hence, the decision variables are the dihedral angles for each 
amino acid that forms the peptide sequence. Specifically, they include the backbone 
dihedral angles: phi (f), psi (j) and omega (w), and also the amino acid side chain 
dihedral angles, chi (c). Table 2-1 shows the detailed numbers of the decision variables 
for peptide Met-enkephalin. 
 
Table 2-1. Number of all the dihedral angles within peptide Met-enkephalin 
Amino Acid Psi angle (f) Psi angle (j) Omega angle (w) Chi angle (c) 
Tyr (Y) 1 1 1 3 
Gly (G) 1 1 1 0 
Gly (G) 1 1 1 0 
Phe (F) 1 1 1 2 
Met (M) 1 1 1 3 
Sum of all dihedral angles: 23 
 
 
2.2.3 Particle Swarm Optimization  
Particle Swarm Optimization has been applied to solve many NP-hard problems. 
We choose PSO in this study because it is simple to implement with only a few parameters 
to adjust. Furthermore, in many cases, PSO converges to the best solution quickly and 
hence it can solve some difficult problems efficiently.  
As denoted in the name, there are two main components for PSO, the swarm and 
the particle. All particles together form a swarm and there is a social component to guide 
them move synergistically. For each individual particle, the movement is influenced by 
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three factors: inertia, cognitive influence and social influences where inertia velocity of a 
particle maintains its capability to explore the search space, cognitive influence comes 
from its personal best history and social influences consider the effect of found global 
best. Therefore, each individual particle tries to achieve self-improvement through both 
cognitive and social influences, and eventually the whole swarm moves towards the best 
area of solution quickly. The two variables being considered for each particle within the 
swarm are velocity and position, and they are updated at each iterative cycle based on the 
equations (1) and (2) below, respectively. 𝑉"#$% = 𝑉"# + 𝜑% ∗ 𝑟%(𝑃" − 𝑋"#) + 𝜑0 ∗ 𝑟01𝑃2 − 𝑋"#3	                                      (1) 𝑋"#$% = 𝑋"# + 𝑉"#$%                                                                                          (2) 
Both parameters, velocity and position, are initialized randomly from the solution 
space. During each cycle, both individual particle best solution (𝑃") and global particle 
best solution (𝑃2) are retained, and velocity and position update their values in a sequential 
order. Briefly, the velocity updates itself by considering all three components (i.e. inertia, 
cognitive influence and social influences), and afterwards, the position simply updates 
itself by adding the updated velocity. The iterative cycle is repeated until termination 
criteria is satisfied.  
2.2.4 Genetic Algorithm  
Genetic Algorithm is a powerful meta-heuristic tool that has been frequently used 
to seek near-optimum solutions for many combinational problems. We also test GA as a 
Met-enkephalin conformation optimizer with the consideration that GA is suitable to 
hybridize with other existing methods, so that we can easily combine, if necessary, with 
other implemented heuristic methods in our study.  
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Overall, GA generates offspring through, firstly, a linear combination of two 
parents as denoted below in equations (3) and (4), where β is	randomized	between	0	and	 1, and secondly, performing crossover with one parent and thirdly, randomly 
selecting one point for mutation to a random value within the solution space. The 
corresponding rate for crossover and mutation being optimized to be 0.8 and 0.1, 
respectively, in our study.  
O1=P1 - β*(P1-P2)                                                                                (3) 
O2=P2 + β*(P1-P2)                                                                               (4) 
Importantly, it is usually not efficient to replace the entire parental generation with 
all new offspring in the children generation. Hence, we applied the elitism to maintain 
high fitness for the continuing population by retaining the top 50% individuals from the 
parental generation and another top 50% individuals from the children generation in terms 
of their fitness values determined by the evaluation function. 
2.2.5 Memetic Algorithm  
The Memetic Algorithm, as a hybrid Genetic Algorithm, was developed in the 
most recent decade and has been successfully applied to solve many real-world problems, 
such as maintenance scheduling [40, 41], gene expression clustering [42] and gene feature 
selection [43]. When combined with the local search, the MA performance proves to be 
an improvement to GA in some problem domains. In this study, we perform a very simple 
MA with the local neighborhood structure being defined as the value of one dihedral 
angle ± 0.5 degrees. Thus, the size of the neighborhood is two-fold of the problem 
dimension.  
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2.2.6 Amber and Pyrosetta Software  
The evaluation function was implemented using the Amber fore field as stated in 
Section 2.2.1, thanks to the contribution from Amber developers who developed the 
Python Application Programmer Interface (API). The Python API makes it possible for 
us to use sander (an Amber module which carries out energy minimization) 
functionalities inside our own Python scripts without worrying about a) how strings map 
to the underlying Fortran code and additionally, or b) bugs arising from uninitialized 
variables (see Amber manual Section 17.13.4 [30]). Specifically, in this study, we 
employed the sander functionality of AMBER software to compute the total potential 
energy of our peptide systems. 
Another important question to tackle is how to generate the new atom coordinates 
after changing the dihedral angles during each iterative cycle. One useful software 
package we employed for this question is called Pyrosetta [44], which is an interactive 
Python-based interface modified based on Rosetta. Pyrosetta enables users to design their 
own molecular modeling algorithms, and we used the software to regenerate new atomic 
coordinates from a set of new dihedral angles.    
 
2.3 Results 
2.3.1 Conversion between Amber and Sybyl Atom Type 
To compute the potential energy of the peptide system, all atomic coordinates 
need to be provided. In this study, we regenerate the coordinates of all peptide atoms 
using Pyrosetta software, which can directly take the dihedral angles of the peptide 
sequence as the input and quickly output the new coordinates. However, a major 
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challenge is that Pyrosetta code utilizes Sybyl atom type, whist Amber package only 
accept Amber atom type. The atom type incompatibility causes problematic cooperativity 
between the two software packages. After a detailed output file comparison, we find that 
the differences between using these two atom types appear as only different atom orders 
(Fig. 2-1).  Specifically, the order of atom coordinates for each amino acid regenerated 
from Pyrosetta need to be reshuffled before passing to Amber software for energy 
calculations. As a solution, we manually find the matching orders for all 20 amino acids 
denoted using either Amber or Sybyl Atom Type, and then use this mapping to link  the 
two software packages. For researchers who may face similar issues whenever need to 
connect the Amber and Pyrosetta, the matching orders from this study can be easily used. 
 
Figure 2-1. Example of atom order difference between Amber atom type and Sybyl atom 
type using amino acid Serine. 
A) Amber atom type expression of amino acid Serine (SER); B) Sybyl atom type expression of 
amino acid Serine (SER). The atom symbol and order differences are highlighted with a red box.  
2.3.2 PSO, GA and MA all Efficiently Minimize Met-enkephalin 
Three heuristic approaches (i.e. PSO, GA and MA) are implemented in this study 
to test and compare the algorithm minimization efficiency on Met-enkephalin.  All three 
algorithms are coded in Python and their corresponding experimental designs can be 
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found in detail in Section 2.2. As shown in the left panel of Figure 2-2, using the 23 
dihedral angles within Met-enkephalin as the decision variables (refer to Table 2-1), all 
three heuristic approaches (i.e. PSO, GA and MA) can obtain minimized Met-enkephalin 
three-dimensional structures with the system total energy below -30.0 kcal/mol (Fig. 2-
2A). Although both of GA and MA converge to minimized conformations with quite 
close total energies, GA performs 2-fold faster than MA. A possible explanation is that 
the MA method needs to spend a non-negligible amount of time to perform the local 
search for each individual before moving to the next iterative generation, which causes 
its slower convergence compared to GA without any local searches. Of note, the PSO 
algorithm stands out strikingly in regard to its efficiency in finding a further lower-energy 
conformation with the least computational effort among the three methods (Fig. 2-2B).  
 
 
Figure 2-2. Efficient structure minimization of Met-enkephalin using PSO, GA and MA 
heuristic methods.  
A) Plot of the energy decrease during Met-encephalin structure minimization using PSO, GA and 
MA; B) Comparison of minimization efficiency between our algorithms and other existing global 
optimizers from literature, including MCM, CSA and 𝝰BB. 
 
To further evaluate the exciting results using our methods, all three algorithms are 
compared with some existing approaches found in the literature, such as Monte Carlo 
Minimization (MCM) [38], Conformational Space Annealing (CSA) [39] and 𝝰-Branch 
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and Bound (𝝰BB) [45] (Fig. 2-2B). The results demonstrate that all three approaches 
implemented herein are comparable, and in particular, our PSO method significantly 
outperforms all other methods. Overall, the study of these three algorithms on a testing 
peptide, Met-enkephalin, lays the foundation to study another novel and longer peptide, 
namely TPP-1. Given these results, we advance PSO and GA methods for the TPP-1 
structure minimization considering their efficient optimization performance.  
 
2.3.3 Minimized Met-enkephalin Structure by PSO 
From the results in Section 2.3.2, PSO minimizes the Met-enkephalin structure to 
a much lower energy than all other applied techniques. Here, we use a molecule graphic 
software, Chimera [46], to represent the minimized lowest-energy Met-enkephalin 
structure (Fig. 2-3, colored in tan). And through comparison with the Met-enkephalin 
structure before running any minimization (Fig. 2-3, colored in cyan), we find that the 
two middle flexible residues, Glycine (G), exist as the overall structural turning points 
after minimization. In addition, the two peptide terminal ends, i.e. the amino and 
carboxylic acid groups, are found in close proximity, indicating electrostatics play a role 
in attracting these two groups after minimization. Furthermore, the optimized structure is 
considered feasible after being submitted to the online software, PROCHECK [47] for 
the stereo-chemical quality evaluation. 
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Figure 2-3. Ribbon representation of Met-enkephalin before and after minimization.  
The ribbon structure colored in Cyan is the linearized Met-enkephalin, i.e. before minimization; 
The ribbon structure colored in Tan is the Met-enkephalin after minimization. Corresponding 
amino acid residues are labeled adjacent to the ribbon structures, Y: Tyrosine, G: Glycine, F: 
Phenylalanine, M: Methionine. 
 
2.4 Discussion  
In the past decades, the Met-enkephalin has attracted considerable interest in the 
area of developing more efficient global optimizers for protein or peptide. In this chapter, 
we choose Met-enkephalin to evaluate our algorithms for the purpose of convenient 
comparison with other existing methods.  
To exclude the discrepancies caused by the continuingly updated force fields, we 
re-calculated the results from literature using the same Amber force field that was used 
in our study. Another interesting point is the mismatching atom orders expressed by 
Amber and Pyrosetta. Although manually assigned atom order correction was used in our 
study to solve this problem, it would be more efficient to develop a script so that the atom 
type conversions can be done automatically within either Amber or Pyrosetta software.  
Based on our experimental data, we found that all three algorithms, i.e. PSO, GA 
and MA, can efficiently minimize the structure of Met-enkephalin to a comparable low-
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energy conformation with other existing methods. Of note, the PSO approach minimizes 
the Met-enkephalin structure very efficiently, outperforming all other methods as shown 
in Figure 2-2. Noticeably, when we compare the performance of MA and GA, MA, with 
the local search, found a slightly lower energy conformation than GA, however, the 
computational cost of MA becomes double of GA. Seemingly, this phenomenon is caused 
by an inefficient local structure refinements. In fact, we have tried multiple local 
neighborhood structures, and none of them can efficiently decrease the CPU cost in 
comparison with GA. In my opinion, a reasonable explanation is that the domain of 
dihedral angles is continuous, and local neighborhood structure works more efficient for 
discrete variables than continuous values. With the optimization results from Met-
enkephalin, we decide to advance both PSO and GA for the TPP-1 structure minimization 
in the Chapter 3.  
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Chapter 3 : Building a Low-energy Pool of TPP-1 Conformers Using 
Hybrid PSO and GA 
 
3.1 Introduction 
Cancer immunotherapy was proposed as far as 100 years ago, but it is only revived 
until recent successes in the clinical studies that target the immune-checkpoint with 
antibodies [48]. The protein-protein interaction between PD-1, programmed death-1 
protein, and its ligand PD-L1, programmed death-1 protein ligand, has become the focal 
target to develop new immune checkpoint antagonists in both clinical and pre-clinical 
trials. Although using antibodies as the immune-checkpoint antagonists have achieved 
effective results in clinical studies, before advancing further towards therapeutic drugs, 
some disadvantages of antibodies still give rise to concerns among researchers, such as 
low oral bioavailability, very long half-life time, low penetration rate and more 
importantly, difficult and expensive production. Taken all the above factors into 
consideration, developing small molecule or peptide antagonists for targeting immune 
checkpoints has become the alternative resort in immunotherapy.   
Until recently, the first Å-resolution crystal structure of human PD-1/PD-L1 has 
been solved [49], which allows researchers to analyze the molecular interactions between 
these two proteins more in detail. Specifically, a large flat and hydrophobic interface was 
found between PD-1 and PD-L1.  This makes it very difficult to develop small organic 
molecule ligands due to either low binding specificity (when enough hydrophilic portion 
was maintained to make them soluble) or low water solubility (when hydrophobic 
moieties were largely included to improve the binding affinity) [50]. Therefore, small 
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organic molecules do not appear to be very promising for this particular target, and 
developing suitable peptide or peptide derivatives to target the immune checkpoint PD-
1/PD-L1 becomes more attractive.     
TPP-1, a 22-mer peptide, was discovered from biological high-throughput 
screening assay and shown to be effective in inhibiting cancer cell proliferation and could 
potentially improve current tumor therapy [14]. TPP-1, which works as a PD-L1 blockade 
agent, binds PD-L1 and disrupts the PD-1/PD-L1 interaction. Since TPP-1 contains only 
naturally occurring amino acids, it is projected to have a higher bioavailability and 
stronger binding selectivity properties than organic molecules.  
At current pre-clinical stage, TPP-1 optimization is critically needed in order to 
design more potent and effective peptide candidates before advancing to furthermore 
comprehensive clinical investigations. Serving as an important component towards this 
goal, building the low-energy pool of TPP-1 structures would be beneficial and expedite 
the process of TPP-1 drug development. 
Most current peptide global optimizers, such as aforementioned MCM, CSA, TS 
or SA in Chapter 2, cannot handle large (>10aa) peptides structural minimization 
efficiently. Given that dihedral angles determine primarily the overall peptide structures 
under biological conditions, in this project, we aim to efficiently collect the low-energy 
conformers of TPP-1 by evolving the combination of amino acid dihedral angles in the 
backbone, i.e. phi (f) and psi (j), and subsequently, running a brief energy minimization 
to adjust any stereo-inappropriate local structures or remove side chain clashes. 
With the advent of more and more complicated problems, single heuristic 
approach cannot solve problem as efficiently as required, alternatively, some researchers 
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have hybridized different heuristic approaches for solving complicated problems by 
taking each of their advantages [51-54]. Inspired by some of these work [52, 54], we are 
also interested in implementing the hybridized PSO and GA for TPP-1 conformational 
search. 
3.2 Methodology 
3.2.1 Energy Evaluation Function 
The same evaluation function from Section 2.2.1 is used to implement energy 
calculations of TPP-1.   
3.2.2 Decision Variables and Search Space 
Here we define the decision variables for TPP-1 similar to the decision variables 
in Section 2.2.2 for Met-enkephalin. TPP-1 sequence includes 22 amino acids, i.e. 
SGQYASYHCWCWRNPGRSGGSK using one letter representation. However, due to 
the search space grows exponentially as the size of the decision variable linearly 
increases. Therefore, to simplify the problem, we only take into the consideration of the 
conformation-dominating dihedral angles, specifically, the backbone dihedral angles: phi 
(f) and psi (j). And the peptide plane dihedral angle omega (w), and amino acid side 
chain dihedral angles chi (c) were not included. For excluded dihedral angles, their values 
were taken by default from the software Pyrosetta. Table 3-1 below shows the detailed 
numbers of the decision variables for TPP-1 peptide. 
 
 
Table 3-1. Number of dihedral angles within peptide TPP-1. 
Amino Acid Psi angle (f) Psi 
angle 
(j) 
Omega angle (w) Chi angle (c) 
Ser (S) 1 1 1 1 
Gly (G) 1 1 1 0 
Gln (Q) 1 1 1 3 
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Tyr (Y) 1 1 1 3 
Ala (A) 1 1 1 0 
Ser (S) 1 1 1 1 
Tyr (Y) 1 1 1 3 
His (H) 1 1 1 2 
Cys (C) 1 1 1 1 
Trp (W) 1 1 1 2 
Cys (C) 1 1 1 1 
Trp (W) 1 1 1 2 
Arg (R) 1 1 1 5 
Asp (D) 1 1 1 2 
Pro (P) 1 1 1 2 
Gly (G) 1 1 1 0 
Arg (R) 1 1 1 5 
Ser (S) 1 1 1 1 
Gly (G) 1 1 1 0 
Gly (G) 1 1 1 0 
Ser (S) 1 1 1 1 
Lys (K) 1 1 1 4 
Sum of all backbone dihedral angles: 44 
Note: The values of dihedral angle w and c are taken from Pyrosetta by default. 
3.2.3 Hybrid PSO-GA 
Both Particle Swarm Optimization (PSO) and Genetic Algorithm (GA) methods 
have been specified in detail in Section 2.2. In this chapter, we implement the algorithms 
similarly for each method per se.  
Hybrid PSO and GA is introduced to this work by performing PSO first and then 
GA. Specifically, one-hundred particles were initialized randomly from the variable 
domain, i.e. from -180° to 180°, for PSO minimization. Taking the quick convergence of 
PSO into a consideration, we output and save the best population of particles after the last 
iterative cycle. Subsequently, fifty chromosomes of GA are randomly selected from the 
aforementioned one-hundred PSO particles instead of being randomly initialized again 
from the whole variable domain. This allows GA to start from lower-energy 
conformations, avoiding a large number of unnecessary searches within poor quality 
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solution space, and thus improving the GA search efficiency. The optimized parameters 
of PSO and GA from Section 2.2 are directly inherited in this chapter.        
3.2.4 Molecular Dynamic Simulation 
The linearized TPP-1 structure, generated from Pyrosetta, is used as the initial 
structure to run molecular dynamics (MD). Specifically, the peptide was solvated in 105 
cubic Å water box, and a 50 nanoseconds (ns) MD simulation is implemented using 
software NAMD on OU Supercomputing Center for Education and Research (OSCER) 
with GPU acceleration. Amber force field is used to model peptide. The MD simulation 
system is equilibrated at 300K for 2 ns. Periodic boundary conditions are selected, and 
long-range electrostatic interactions are calculated with particle mesh Ewald method, 
with non-bonded cutoff set to 12.0 Å and SHAKE algorithm is used to constrain bonds 
involving hydrogen atoms. Time step is 2 femtoseconds (fs) and the trajectories are 
recorded every 10 picoseconds (ps). 
 
3.3 Results 
3.3.1 Hybrid PSO-GA Minimizes TPP-1 More Efficiently Than PSO or GA 
In this experiment, we implement both PSO and GA in TPP-1 structure 
minimization with 44 peptide backbone dihedral angles, i.e. the phi (f) and psi (j) angles, 
being used as the decision variables. As the results show, neither PSO nor GA itself can 
minimize TPP-1 efficiently. Note that when the PSO implementation converges, no 
further improvement is obtained with more iteration cycles (Fig. 3-1A). In contrast, when 
the PSO and GA algorithms are hybridized following the procedures specified in Section 
3.2.3, we find a significant increase of the structure minimization efficiency (Fig. 3-1B). 
Hybrid PSO-GA further minimizes the TPP-1 structure to a conformation at around -100 
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kcal/mol from the conformation minimized by PSO at around 300 kcal/mol. This 
hybridization also outperforms GA, which only minimizes TPP-1 to a conformation at 
about -9 kcal/mol. Overall, the performance of hybrid PSO-GA is significantly more 
efficient than using single heuristic method. 
 
 
Figure 3-1.Comparison of the minimization efficiency between GA, PSO and hybrid PSO-
GA. 
A) The TPP-1 structure is minimized with either PSO algorithm (blue line) or GA (red line); B) 
The TPP-1 structure is minimized with a hybrid algorithm, i.e. GA (red line) is subsequently 
performed after PSO (blue line) minimization. 
 
3.3.2 A Pool of Lower-energy TPP-1 Conformers 
Following the same approach as used in Section 3.3.1, we collect 30 low-energy 
conformations of TPP-1 by randomly selecting 50 particles from the PSO minimization 
and advancing them to the GA step as the initial chromosomes. After computing the 
energies of all 30 TPP-1 conformers, we arbitrarily choose the top ten lowest-energy 
conformations to build the low-energy TPP-1 pool. Interestingly, we find that all ten low-
energy conformers have unique structural conformations (Fig 3-2A), indicating the 
conformation flexibility property of peptide folding. Furthermore, Ramachandran plot 
([55]) of the phi-psi (f-j) torsion angles are used to validate the stereo-chemical quality 
and feasibilities of all TPP-1 conformations minimized by hybrid PSO-GA. A 
Ramachandran plot built from 500 non-homologous proteins is used as a dihedral angle 
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feasibility reference [56] (shown in Figure 3-2B). And all our 30 minimized TPP-1 
structures are used to generate a similar plot to compare (Figure 3-2C). Through this 
comparison, we find that a majority of the structures adapted b-strand as its main 
secondary structure with some of them also maintaining a-helix structures locally. See 
Figure 3-2A for a depiction of these results. Quantitatively, above 90% of the dihedral 
angles fell into the favorable or additional allowed regions in the Ramachandran plot, 
given by the online software PROCHECK [47].  
 
 
Figure 3-2. A Diversified low-energy conformation pool of TPP-1. 
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A) Ribbon representation of top 10 TPP-1 low-energy conformers, prepared using software UCSF 
Chimera; B) Ramachandran plot from published literature [56]; C) The Ramachandran plot for 
TPP-1 low-energy conformers from this study. 
 
 
3.3.3 Comparable Results from Hybrid PSO-GA and Molecular Dynamic 
Simulation 
Table 3-2. Comparison between hybrid PSO-GA and Molecular Dynamic simulation. 
 
 
              Note: * done by 10,000 steps steepest descent algorithm, unit: kcal/mol. 
 
 
To rationally evaluate the efficiency of our PSO-GA algorithm, conventional 
theoretical calculation, i.e. Molecular Dynamics (MD) simulation under the force field, 
was performed to minimize TPP-1 structure from a linearized configuration. As the 
results in Table 3-2 show, after a 10 ns and 50 ns MD simulation, the TPP-1 structure was 
minimized to conformations at energy -517.41 and -563.67 kcal/mol, respectively. As a 
comparison, we find that the TPP-1 conformers minimized using our hybrid PSO-GA 
approach are comparable with the MD simulation results (Table 3-2). In terms of the 
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computational efficiency, a 10 ns MD simulation requires ~20 hours computational cost 
with GPU acceleration (20 cores) on the University of Oklahoma Supercomputing Center 
(OSCER). In contrast, our hybrid PSO-GA requires only 2-3 hours on only one CPU core 
and achieved even lower energy conformers. When considering the fact that normally 
GPU accelerates calculations 6~7 times (over a 20-core CPU node), our PSO-GA 
algorithm improves the conformational search efficiency by at least two orders of 
magnitude. Moreover, it is encouraging that the hybrid PSO-GA also obtained stereo-
chemically reasonably structures. Therefore, using the established hybrid PSO-GA 
algorithm, we can quickly generate a pool of low-energy conformers for peptides, and 
this low-energy structure pool can be potentially used as valuable initial structures for 
subsequent peptide molecular docking and peptide-protein binding free energy 
calculations. 
 
3.4 Discussion 
Peptide conformational search has been a challenging scientific task for many 
decades and due to its conformation flexibility, finding only the global minimum structure 
may not suit some research needs.  
In this study, in order to meet an increasing demand for peptide drug development 
in the field of cancer immunotherapy recently, we choose a promising PD-L1 inhibiting 
peptide, TPP-1, as our studying target. We apply a hybridized PSO and GA approach to 
minimize the TPP-1 structure. More importantly, our goal is to build a low-energy 
structure pool of TPP-1 other than finding only the global minimum structure.  
As our results show in Figure 3-1, hybrid PSO-GA is more efficient in searching 
for minimized TPP-1 structures than either PSO or GA itself. And notably, multiple TPP-
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1 low-energy structures can be collected within only couple days using one single laptop 
(Table 3-2). Overall, these minimized structures are also sterically feasible as shown on 
the Ramachandran plot (Fig. 3-2C). When compared with the conventional Molecular 
Dynamics simulation approach, our hybrid PSO-GA stands out significantly as it 
increases TPP-1 structure minimization efficiency by more than two orders of magnitude 
(Table 3-2). 
In our study, no constraints were applied on the decision variables, meaning all 
the chosen dihedral angles were allowed to continuously change from -180° to 180°. 
However, it should be easy to adapt this algorithm for one who works with discrete 
variables. Previously, multiple studies applied heuristic methods to minimize peptide 
structures and they all applied restraints onto the dihedral angles in order to save 
computational cost [39, 45].  Therefore, our hybrid PSO-GA has higher chances of 
finding more low-energy conformations.      
We conclude that the hybrid PSO-GA is well suited for conformational searches 
of peptides. Especially, it could be a very important study to conduct for peptide-involved 
structure optimization or binding affinity investigations. It is obvious that our hybrid 
PSO-GA can be further improved if one can spend more time on the parameter tuning 
and optimization. In addition, working on different peptides, some of the parameters may 
need re-adjustment, such as the population size of GA, the inertia constant and also the 
constants for cognitive or social components of PSO. 
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Chapter 4 : Overall Summary and Future Directions 
 
How to efficiently search the low-energy conformation, especially for biological 
macromolecules remains a difficult question. This work aims to improve current peptide 
conformational search methods using meta-heuristic approaches. In particular, our study 
focused on improving peptide conformational searching in order to benefit researchers 
either studying peptide-protein interactions or developing peptide-involved drug design.  
Instead of just searching the global minimum structure, we built a low-energy 
conformer pool for a promising PD-L1 inhibiting polypeptide, TPP-1. Using the peptide 
backbone dihedral angles as the decision variables, both PSO and GA can outperform 
other existing approaches in minimizing the Met-enkephalin, a benchmarking 
pentapeptide for judging the efficiency of conformation optimizers. However, neither 
PSO and GA performed well on minimizing TPP-1, instead, we found that hybridizing 
PSO and GA can minimize TPP-1 structure efficiently. Strikingly, the efficiency of 
hybrid PSO-GA is hundreds-fold faster than the conventional Molecular Dynamic 
simulations running under the force filed. Meanwhile, the stereo-chemical quality of the 
minimized structures was also validated using Ramachandran plot. Overall, our hybrid 
PSO-GA minimization approach can benefit biochemical and biomedical researches with 
the demand of determining polypeptide conformations and hence can advance the field 
of studying peptide-involved anti-cancer drugs.  
For the future directions, another important question need to address is to obtain 
the trajectory cluster analysis result after peptide MD simulations. In theory, the overall 
structure moves towards low-energy conformations under the force field, but it may take 
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a long time for the simulation to escape certain local minima along the simulation path 
due to the reason that these local minima are already quite stable conformations with very 
low energies. Although the simulated structure at the simulation endpoint typically has a 
very low energy, it is still important to know all the low energy conformations within the 
entire MD simulation trajectory. Such a way, the comparison between minimized 
structures from hybrid PSO-GA and low-energy structures from the MD cluster analysis 
can give us more confidence on determining the robustness of the PSO-GA optimizer. 
Given more time on this thesis project, I would like to perform the trajectory cluster 
analysis using Amber Package. And furthermore, for structural similarity comparisons, 
the ‘match maker’ function in software UCSF Chimera can be utilized to align structure 
to structure. 
In peptide structure optimization studies, there are typically two main cases: either 
seeking more potent peptide interactions to achieve effective results or reducing some 
peptide interactions to an appropriate range to maintain its interaction reversibility. In 
either scenario, besides natural amino acids, some unnatural amino acids, which only 
differ in the side chains from 20 natural amino acids, may be introduced into the peptide 
sequence to help tune the peptide-protein binding affinity. And here, we propose that our 
method can work efficiently in a similar manner to meet either goal because we only used 
the backbone dihedral angles as the decision variables in our hybrid PSO-GA. But the 
side chain dihedral angles or clashes will be taken care of by a short (~s) steepest 
minimization step at the end. However, we expect this method to work well for peptide 
derivatives, which involves small organic moieties, although extensive testing will be 
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needed. But this could be another interesting future project to expand the applicability of 
our methods onto different types of biomolecules optimizations.  
Overall, as a proof of concept, this study demonstrates that hybridized meta-
heuristic strategies can be more efficiently applied to expedite peptide conformational 
searching. It significantly accelerates short peptide conformation searching by at least 
two orders of magnitude (while reaching similar quantity of results) than conventional 
MD simulations.     
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Appendix 
 
 
Figure 1. GA population size optimization results. TPP-1 energy minimization using seven 
different representative population sizes were shown above. Energy on the y-axis was cut at 
4000kcal/mol for convenient illustration and comparison. 
 
 
 
 
 
Figure 2. Ramachandran plot for optimized Met-enkephalin using PSO. 
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Figure 3. TPP-1 primary sequence and primary structure. 
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Table 1. All amino acids backbone dihedral angles for Met-enkephalin in the optimized 
structure by PSO. 
 
# Amino 
acid 
f (Phi) j (Psi) 
1 Tyr -150.3 118.8 
2 Gly 104.4 143.3 
3 Gly 71.7 -85.4 
4 Phe -130.2 -67.8 
5 Met -85.97 -21.6 
                                        _____________________________________ 
                                        Note: all the angles are expressed in degree (°). 
 
 
 
Table 2. All amino acids backbone dihedral angles for TPP-1 in the lowest-energy structure 
optimized by Hybrid PSO-GA. 
 
# Amino acid f (Phi) j (Psi) # Amino acid f (Phi) j (Psi) 
1 Ser -47.6 156.1 12 Trp -85.6 82.9 
2 Gly -122.0 -68.8 13 Arg 145.6 22.8 
3 Gln -153.5 55.1 14 Asp -122.4 72.6 
4 Tyr 154.9 122.0 15 Pro -37.9 6.3 
5 Ala 53.4 61.6 16 Gly 121.1 55.0 
6 Ser -61.9 -44.5 17 Arg -80.0 90.8 
7 Tyr 139.6 45.3 18 Ser -140.4 -45.7 
8 His -67.7 120.8 19 Gly 121.1 22.8 
9 Cys -85.6 122.7 20 Gly -139.5 88.8 
10 Trp 84.4 93.3 21 Ser -92.6 114.2 
11 Cys -73.6 116.3 22 Lys 135.4 48.8 
  _____________________________________ 
  Note: all the angles are expressed in degree (°). 
 
